Mephtetramine (MTTA) – Side Effects, Uses & Risk Factors

Mephtetramine (MTTA) is a synthetic compound identified by researchers as a novel psychoactive substance (NPS). MTTA was first spotted in scientific literature about 2013 when it was found amongst substances sold online as so-called research chemicals. Later, researchers studied its chemical structure, metabolism and possible toxicological effects.

Given the limited research on MTTA, online descriptions should not be treated as established medical information. Instead, the current evidence supports considering MTTA mainly from a scientific, analytical and toxicological point of view.

What is Mephtetramine (MTTA) ?

2-((methylamino)methyl)-3,4-dihydronaphthalen-1(2H)-one. Mephtetramine is commonly abbreviated as MTTA. Its molecular formula is C 12 H 15 NO and its molecular weight is about 189.25 g/mol as per PubChem.

Researchers consider MTTA to be a stimulant NPS and its structure is related to the larger family of synthetic cathinone-like compounds. But the chemical structure of this molecule is different from that of typical cathinones due to the different arrangement of the amine-containing side chain.

Chemicals Information

Some of the identifiers are:

• Mephtetramine Common name:
• MTTA Abbreviation:
• Molecular formula: C₁₂H₁₅NO
• Molecular weight: About 189.25 g/mol
• Chemical class: New psychoactive substance
• Classification of research: NPS of stimulant type
• Systematic name 2-[(Methylamino)methyl]-3,4-dihydro-2H-naphthalen-1-one
• PubChem CID: 69845357

Mephtetramine Research History

As the NPS market was changing rapidly, the scientists identified MTTA in the early 2010s. A 2014 study described mephtetramine and other emerging compounds that had been appearing on websites selling substances as “research chemicals.” These substances have been characterised by analytical techniques and their metabolism was also studied.

Subsequently, further studies have identified MTTA in confiscated material and developed analytical procedures for the detection of the compound and its metabolites in biological samples. This work is important because NPS compounds can be extensively metabolised, which can make identification in the laboratory more difficult.

What is the effect of MTTA on the organism?

However, the available scientific evidence does not provide enough information to establish a reliable human pharmacological profile for MTTA. However, researchers have described it as a stimulant NPS and experimental studies have investigated alterations in physiological and behavioural parameters.

Important to keep in mind that animal studies cannot automatically predict the effects or safety of a substance in humans. One mouse study reported changes in motor activity, breathing rate, temperature, blood parameters and tissue findings following repeated experimental exposure. The researchers pointed to possible toxicity to organs from the heart to the liver and kidneys.

Therefore, users should not assume that experimental results indicate MTTA is safe or appropriate for human consumption.

Why Do We Need More Research?

MTTA has a relatively limited evidence base in scientific terms compared with established medicines. Researchers have studied its metabolism and toxicology, but key questions about long-term effects, human pharmacology, interactions and safety remain unanswered.

Furthermore, a 2023 study specifically mentioned that very little was known about the pharmacological and toxicological profile of MTTA.

Metabolism and detection of mephtetramine

Scientists have looked at how the body processes MTTA because metabolites can be identified by forensic and toxicology labs and therefore exposure can be detected.

Studies of biological samples did not show change in MTTA and several metabolites. The results indicated that the compound is metabolised and different biological specimens may contain different detectable compounds.

Consequently, laboratories involved in NPS exposure studies may require special analytical techniques, and not only routine drug screening.

Safety and Risks Issues

MTTA is not approved as a medicine or as a proven dietary supplement. As an NPS it means that reliable human safety information is still limited.

Experimental evidence also raises toxicological concerns. Animal studies reported changes in blood and urine parameters and histological changes in heart, liver and kidneys.

More generally, stimulant-like substances may have cardiovascular and neurological risks. The FDA’s safety info for prescription stimulants also highlights that stimulant misuse can lead to serious outcomes like addiction, overdose, and cardiovascular problems.

Is Mephtetramine a Medically Approved Drug?

The evidence available in the sources studied here does not prove that MTTA is an approved therapeutic medicine. So, it should not be marketed as a treatment for ADHD, weight loss, depression, fatigue, or any other medical condition.

Rather, within the framework of NPS identification, analytical chemistry, metabolism, pharmacology and toxicology, MTTA is mainly presented by researchers.

Mephtetramine (MTTA) – Final Thoughts

Mephtetramine (MTTA) is a synthetic stimulant-like new psychoactive substance that emerged in the early 2010s. Its chemical identity, metabolism, biological detection, and potential toxicological effects have been characterised by researchers.

However, scientific knowledge about MTTA is limited. Therefore, any claims made about its benefits, safety, dosage, or suitability for human consumption should be treated with scepticism. Current research supports the view of MTTA as a subject for scientific and toxicological study rather than as a proven medicine or supplement.

If someone has been exposed to an unknown stimulant or NPS and has serious symptoms, the most appropriate thing to do is seek immediate medical attention.